Clinical Trials · NCT01324505
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 43
- Start date
- Mar 2011
- Locations
- 1 site, Germany
- Primary endpoint
- Area under the ethinylestradiol concentration-time curve